AstraZeneca’s LATIFY Trial Misses Primary Endpoint in Previously Treated Advanced NSCLC
- January 20, 2026
Oligodendrocyte‑Targeted Gene Therapy Shows Breakthrough Potential in Canavan Disease
Hidden Protein Markers Offer New Hope for Predicting Prostate Cancer Across Diverse Communities
MHRA Grants New Indication for argenx’s Vyvgart in Chronic Inflammatory Demyelinating Polyneuropathy
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Patient Worthy is looking for individuals who are interested in sharing their experiences with Attention-Deficit/Hyperactivity Disorder (ADHD).
By opening up about your healthcare experiences, you can help others navigate their own paths with confidence and hope. You can be the spark that reminds someone they are not alone.
If you’d like to learn more or join this week’s community conversation, visit Patientworthy.com for the latest updates.
And if you’re ready to share your story, simply click the link below.
bit.ly/4dV7gru
#ADHD #PatientWorthy #ShareYourStory
🧠 ADHD isn’t just about being easily distracted—it’s a unique way the brain processes attention and energy. Understanding these differences can help people approach tasks, learning, and focus with more patience and strategy. ✨
💡 Tip: Small adjustments to your environment or routines can make a big difference in managing attention and productivity. #ADHD #ADHDAwareness #ShareYourStory #PatientWorthy
If you're interested in sharing your story, click here: bit.ly/4dV7gru
This week on Patient Worthy's site, we're shining a spotlight on Attention-Deficit/Hyperactivity Disorder (ADHD). Throughout the week, we’ll be sharing valuable insights, exploring potential treatment options, and creating space for patients and caregivers to share their personal journeys.
If you're interested in learning more or joining the conversation, visit Patientworthy.com for the latest updates.
Have a story to share? Click the link below, we'd love to hear from you!
bit.ly/4dV7gru
#ADHD #PatientWorthy #ShareYourStory
